Learn how you can join the EBONI Study at a location near you
- What is the EBONI study?
The EBONI study is for Black/African American women who are interested in preventing HIV by using APRETUDE, a long-acting injectable PrEP. We want to help providers figure out best practices for using APRETUDE in their clinic and identify ways in which to support women receiving APRETUDE.
Your insights have the potential to address the unequal rates of HIV in Black/African American women where you live.
- Is APRETUDE an experimental drug?
No. APRETUDE is approved by the FDA.
EBONI is a phase 4 implementation research clinical trial. Phase 4 studies happen after a drug is approved by the FDA. This study is not intended to further test that the drug works and is safe.
- What is the EBONI study trying to understand?
To disrupt the impact of HIV among Black/African American women, it’s important to understand your experiences, views, perceptions and reasons for PrEP care. This study seeks to understand:
- Your interactions with providers
- How easy or hard it is for you to receive APRETUDE
- How APRETUDE works for you
- What you think about APRETUDE
- If certain tools and information about APRETUDE can help you understand, start and maintain PrEP
- How your provider delivers APRETUDE in clinic
- Your awareness of HIV prevention and PrEP
- Who is eligible to participate?
You are eligible to participate in EBONI if you are:
- 18 years or older
- Identify as Black or African American